O	0	7	Effects
O	8	10	of
B-intervention	11	18	pilates
I-intervention	19	28	exercises
O	29	31	on
B-condition	32	42	functional
I-condition	43	51	capacity
I-condition	51	52	,
I-condition	53	64	flexibility
I-condition	64	65	,
I-condition	66	73	fatigue
I-condition	73	74	,
I-condition	75	85	depression
I-condition	86	89	and
I-condition	90	97	quality
I-condition	98	100	of
I-condition	101	105	life
O	106	108	in
O	109	115	female
O	116	122	breast
O	123	129	cancer
O	130	138	patients
O	138	139	:
O	140	141	a
O	142	152	randomized
O	153	163	controlled
O	164	169	study
O	169	170	.

O	171	176	There
O	177	180	are
O	181	185	very
O	186	189	few
O	190	200	randomized
O	201	211	controlled
O	212	219	studies
O	220	222	on
O	223	231	exercise
O	232	234	in
O	235	241	cancer
O	242	250	patients
O	250	251	.

O	252	264	Consequently
O	264	265	,
O	266	271	there
O	272	275	are
O	276	278	no
O	279	289	guidelines
O	290	299	available
O	300	304	with
O	305	311	regard
O	312	314	to
O	315	318	the
O	319	328	exercises
O	329	333	that
O	334	337	can
O	338	340	be
O	341	352	recommended
O	353	356	and
O	357	369	difficulties
O	370	373	are
O	374	385	encountered
O	386	388	in
O	389	392	the
O	393	401	clinical
O	402	410	practice
O	411	413	as
O	414	416	to
O	417	422	which
O	423	431	exercise
O	432	434	is
O	435	439	more
O	440	448	suitable
O	449	451	to
O	452	455	the
O	456	464	patients
O	464	465	.

O	466	469	The
O	470	477	purpose
O	478	480	of
O	481	485	this
O	486	491	study
O	492	495	was
O	496	498	to
O	499	510	investigate
O	511	514	the
O	515	521	impact
O	522	524	of
O	525	532	pilates
O	533	542	exercises
O	543	545	on
O	546	554	physical
O	555	566	performance
O	566	567	,
O	568	579	flexibility
O	579	580	,
O	581	588	fatigue
O	588	589	,
O	590	600	depression
O	601	604	and
O	605	612	quality
O	613	615	of
O	616	620	life
O	621	623	in
B-eligibility	624	629	women
I-eligibility	630	633	who
I-eligibility	634	637	had
I-eligibility	638	642	been
I-eligibility	643	650	treated
I-eligibility	651	654	for
I-eligibility	655	661	breast
I-eligibility	662	668	cancer
O	668	669	.

O	670	680	Randomized
O	681	691	controlled
O	692	697	trial
O	697	698	.

O	699	702	Out
O	703	710	patient
O	711	716	group
O	716	717	,
O	718	728	Department
O	729	731	of
O	732	740	Physical
O	741	749	Medicine
O	750	753	and
O	754	768	Rehabilitation
O	769	772	and
O	773	780	Medical
O	781	789	Oncology
O	790	800	Department
O	800	801	,
O	802	812	University
O	813	821	Hospital
O	821	822	.

B-total-participants	823	828	Fifty
I-total-participants	828	829	-
I-total-participants	829	832	two
O	833	841	patients
O	842	846	with
O	847	853	breast
O	854	860	cancer
O	861	865	were
O	866	873	divided
O	874	878	into
O	879	885	either
O	886	893	pilates
O	894	902	exercise
O	903	904	(
O	904	909	group
O	910	911	1
O	911	912	)
O	913	916	and
B-control	917	924	control
I-control	925	930	group
O	931	932	(
O	932	937	group
O	938	939	2
O	939	940	)
O	940	941	.

O	942	950	Patients
O	951	953	in
O	954	959	Group
O	960	961	1
O	962	971	performed
O	972	979	pilates
O	980	983	and
O	984	988	home
O	989	998	exercises
O	999	1002	and
O	1003	1011	patients
O	1012	1014	in
O	1015	1020	group
O	1021	1022	2
O	1023	1032	performed
O	1033	1037	only
O	1038	1042	home
O	1043	1052	exercises
O	1052	1053	.

O	1054	1061	Pilates
O	1062	1070	exercise
O	1071	1079	sessions
O	1080	1084	were
O	1085	1094	performed
O	1095	1100	three
O	1101	1106	times
O	1107	1108	a
O	1109	1113	week
O	1114	1117	for
O	1118	1119	a
O	1120	1126	period
O	1127	1129	of
O	1130	1135	eight
O	1136	1141	weeks
O	1142	1144	in
O	1145	1148	the
O	1149	1163	rehabilitation
O	1164	1168	unit
O	1168	1169	.

O	1170	1178	Subjects
O	1179	1183	were
O	1184	1192	assessed
O	1193	1199	before
O	1200	1203	and
O	1204	1209	after
O	1210	1224	rehabilitation
O	1225	1232	program
O	1232	1233	,
O	1234	1238	with
O	1239	1246	respect
O	1247	1249	to
O	1249	1250	,
O	1251	1252	6
O	1252	1253	-
O	1253	1256	min
O	1257	1261	walk
O	1262	1266	test
O	1267	1268	(
O	1268	1272	6MWT
O	1272	1273	)
O	1273	1274	,
O	1275	1283	modified
O	1284	1287	sit
O	1288	1291	and
O	1292	1297	reach
O	1298	1302	test
O	1302	1303	,
O	1304	1309	Brief
O	1310	1317	Fatigue
O	1318	1327	Inventory
O	1328	1329	(
O	1329	1332	BFI
O	1332	1333	)
O	1333	1334	,
O	1335	1339	Beck
O	1340	1350	Depression
O	1351	1356	Index
O	1357	1358	(
O	1358	1361	BDI
O	1361	1362	)
O	1363	1366	and
O	1367	1370	the
O	1371	1379	European
O	1380	1392	Organisation
O	1393	1396	for
O	1397	1405	Research
O	1406	1409	and
O	1410	1419	Treatment
O	1420	1422	of
O	1423	1429	Cancer
O	1430	1437	Quality
O	1438	1440	of
O	1441	1445	Life
O	1446	1449	C30
O	1450	1451	(
O	1451	1456	EORTC
O	1457	1460	QLQ
O	1460	1461	-
O	1461	1464	C30
O	1464	1465	)
O	1466	1469	and
O	1470	1475	EORTC
O	1476	1479	QLQ
O	1480	1484	BR23
O	1484	1485	.

O	1486	1491	After
O	1492	1495	the
O	1496	1504	exercise
O	1505	1512	program
O	1512	1513	,
O	1514	1526	improvements
O	1527	1531	were
O	1532	1540	observed
O	1541	1543	in
O	1544	1549	Group
O	1550	1551	1
O	1552	1554	in
B-outcome	1555	1556	6
I-outcome	1556	1557	-
I-outcome	1557	1563	minute
I-outcome	1564	1568	walk
I-outcome	1569	1573	test
O	1573	1574	,
B-outcome	1575	1578	BDI
O	1578	1579	,
B-outcome	1580	1585	EORTC
I-outcome	1586	1589	QLQ
I-outcome	1589	1590	-
I-outcome	1590	1593	C30
I-outcome	1594	1604	functional
O	1604	1605	,
O	1606	1609	and
B-outcome	1610	1615	EORTC
I-outcome	1616	1619	QLQ
I-outcome	1619	1620	-
I-outcome	1620	1623	C30
I-outcome	1624	1628	BR23
I-outcome	1629	1639	functional
I-outcome	1640	1646	scores
O	1647	1648	(
O	1648	1649	P
O	1649	1650	<
O	1650	1651	0
O	1651	1652	.
O	1652	1654	05
O	1654	1655	)
O	1655	1656	.

O	1657	1659	In
O	1660	1668	contrast
O	1668	1669	,
B-outcome	1670	1672	no
I-outcome	1673	1684	significant
I-outcome	1685	1696	improvement
O	1697	1700	was
O	1701	1709	observed
O	1710	1712	in
O	1713	1718	Group
O	1719	1720	2
O	1721	1726	after
O	1727	1730	the
O	1731	1739	exercise
O	1740	1747	program
O	1748	1750	in
O	1751	1754	any
O	1755	1757	of
O	1758	1768	parameters
O	1769	1771	in
O	1772	1782	comparison
O	1783	1785	to
O	1786	1789	the
O	1790	1793	pre
O	1793	1794	-
O	1794	1802	exercise
O	1803	1809	period
O	1810	1811	(
O	1811	1812	P
O	1812	1813	>
O	1813	1814	0
O	1814	1815	.
O	1815	1817	05
O	1817	1818	)
O	1818	1819	.

O	1820	1824	When
O	1825	1828	the
O	1829	1832	two
O	1833	1841	exercise
O	1842	1848	groups
O	1849	1853	were
O	1854	1862	compared
O	1862	1863	,
O	1864	1869	there
O	1870	1874	were
O	1875	1886	significant
B-outcome	1887	1898	differences
I-outcome	1899	1901	in
I-outcome	1902	1906	6MWT
I-outcome	1907	1909	in
I-outcome	1910	1917	pilates
I-outcome	1917	1918	-
I-outcome	1918	1926	exercise
I-outcome	1927	1932	group
O	1933	1934	(
O	1934	1935	P
O	1935	1936	<
O	1936	1937	0
O	1937	1938	.
O	1938	1940	05
O	1940	1941	)
O	1941	1942	.

O	1943	1950	Pilates
O	1951	1960	exercises
O	1961	1964	are
B-outcome	1965	1974	effective
I-outcome	1975	1978	and
I-outcome	1979	1983	safe
O	1984	1986	in
O	1987	1993	female
O	1994	2000	breast
O	2001	2007	cancer
O	2008	2016	patients
O	2016	2017	.

O	2018	2023	There
O	2024	2026	is
O	2027	2028	a
O	2029	2033	need
O	2034	2037	for
O	2038	2045	further
O	2046	2053	studies
O	2054	2056	so
O	2057	2061	that
O	2062	2065	its
O	2066	2072	effect
O	2073	2076	can
O	2077	2079	be
O	2080	2089	confirmed
O	2089	2090	.

O	2091	2095	This
O	2096	2101	study
O	2102	2111	addressed
O	2112	2115	the
O	2116	2123	effects
O	2124	2126	of
O	2127	2134	pilates
O	2135	2143	exercise
O	2143	2144	,
O	2145	2147	as
O	2148	2149	a
O	2150	2153	new
O	2154	2162	approach
O	2162	2163	,
O	2164	2166	on
O	2167	2177	functional
O	2178	2186	capacity
O	2186	2187	,
O	2188	2195	fatigue
O	2195	2196	,
O	2197	2207	depression
O	2208	2211	and
O	2212	2219	quality
O	2220	2222	of
O	2223	2227	life
O	2228	2230	in
O	2231	2237	breast
O	2238	2244	cancer
O	2245	2253	patients
O	2254	2256	in
O	2257	2261	whom
O	2262	2267	there
O	2268	2271	are
O	2272	2278	doubts
O	2279	2288	regarding
O	2289	2292	the
O	2293	2301	efficacy
O	2302	2305	and
O	2306	2316	usefulness
O	2317	2319	of
O	2320	2323	the
O	2324	2332	exercise
O	2332	2333	.
